SMT201500297B - Emulsione olio-in-acqua di mometasone e propilene glicole - Google Patents

Emulsione olio-in-acqua di mometasone e propilene glicole

Info

Publication number
SMT201500297B
SMT201500297B SM201500297T SM201500297T SMT201500297B SM T201500297 B SMT201500297 B SM T201500297B SM 201500297 T SM201500297 T SM 201500297T SM 201500297 T SM201500297 T SM 201500297T SM T201500297 B SMT201500297 B SM T201500297B
Authority
SM
San Marino
Prior art keywords
momethasone
oil
water emulsion
glycol propylene
propylene
Prior art date
Application number
SM201500297T
Other languages
English (en)
Inventor
Henri Hansson
Anna Karin Morén
Original Assignee
Galenica Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galenica Ab filed Critical Galenica Ab
Publication of SMT201500297B publication Critical patent/SMT201500297B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
SM201500297T 2009-05-12 2015-11-30 Emulsione olio-in-acqua di mometasone e propilene glicole SMT201500297B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200900601 2009-05-12
PCT/EP2010/002921 WO2010130428A1 (en) 2009-05-12 2010-05-12 Oil-in-water emulsion of mometasone and propylene glycol

Publications (1)

Publication Number Publication Date
SMT201500297B true SMT201500297B (it) 2016-01-08

Family

ID=42352732

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201500297T SMT201500297B (it) 2009-05-12 2015-11-30 Emulsione olio-in-acqua di mometasone e propilene glicole

Country Status (20)

Country Link
US (2) US8728497B2 (it)
EP (2) EP2429510B1 (it)
JP (2) JP5833541B2 (it)
CN (1) CN102458382B (it)
AU (1) AU2010246613B2 (it)
BR (1) BRPI1010907B8 (it)
CA (1) CA2761739C (it)
CY (1) CY1116667T1 (it)
DK (1) DK2429510T3 (it)
ES (2) ES2813400T3 (it)
HR (1) HRP20150959T1 (it)
HU (1) HUE027718T2 (it)
MX (1) MX345888B (it)
NZ (1) NZ596429A (it)
PL (2) PL2429510T3 (it)
PT (1) PT2429510E (it)
RU (1) RU2526911C2 (it)
SI (1) SI2429510T1 (it)
SM (1) SMT201500297B (it)
WO (1) WO2010130428A1 (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE027718T2 (en) 2009-05-12 2016-10-28 Galenica Ab Oil-in-water emulsion containing mometasone and propylene glycol
PT105982B (pt) * 2011-11-03 2014-07-29 Laboratório Edol Produtos Farmac Uticos S A Composição e método de preparação a frio de uma emulsão utilizada como veículo de fármacos anti-inflamatórios
JP7262227B2 (ja) * 2017-10-23 2023-04-21 マルホ株式会社 被膜形成外用剤
WO2019182969A1 (en) * 2018-03-19 2019-09-26 Essential Lipid Technologies, LLC Topical phospholipid formulations and methods for preparing the same

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4282216A (en) * 1977-04-20 1981-08-04 Johnson & Johnson Topical anti-inflammatory drug therapy
US4808610A (en) * 1986-10-02 1989-02-28 Schering Corporation Mometasone furoate anti-inflammatory cream composition using hexylene glycol
AU6974191A (en) * 1989-12-20 1991-07-18 Schering Corporation Stable cream and lotion bases for lipophilic drug compositions
US6127353A (en) 1991-09-06 2000-10-03 Schering Corporation Mometasone furoate monohydrate, process for making same and pharmaceutical compositions
WO1994013257A1 (en) * 1992-12-16 1994-06-23 Creative Products Resource Associates, Ltd. Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder
US5696105A (en) * 1996-03-14 1997-12-09 Hackler; Walter A. Antifungal nail composition
US5952003A (en) * 1996-08-01 1999-09-14 Novartis Corporation Terazosin capsules
US6075056A (en) 1997-10-03 2000-06-13 Penederm, Inc. Antifungal/steroid topical compositions
US6720001B2 (en) * 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
US7030203B2 (en) * 2001-09-28 2006-04-18 3M Innovative Properties Company Water-in-oil emulsions with ethylene oxide groups, compositions, and methods
PE20030828A1 (es) * 2002-03-04 2003-11-04 Novartis Ag Composicion oftalmica que comprende ascomicina
TR200201343A2 (tr) * 2002-05-17 2003-12-22 Orva İlaç Sanayi̇ Ve Ti̇caret A. Ş. Kortikosteroid ve antiseptik içeren farmasötik bileşim
DK1542904T3 (da) 2002-08-27 2008-04-21 Schering Corp Fremgangsmåde til fremstilling af formuleringer til en inhalator med målte doser
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20060104968A1 (en) * 2003-03-05 2006-05-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
WO2004105686A2 (en) * 2003-05-23 2004-12-09 Taro Pharmaceuticals U.S.A., Inc. Novel topical steroid cream formulations
JP2007500231A (ja) 2003-05-23 2007-01-11 コンビナトアールエックス インコーポレーティッド 新生物を治療するための併用治療
US20050196462A1 (en) * 2003-12-30 2005-09-08 Oculus Innovative Sciences, Inc. Topical formulation containing oxidative reductive potential water solution and method for using same
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
DE102006034883A1 (de) * 2006-07-25 2008-01-31 Hermal Kurt Herrmann Gmbh & Co. Ohg Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat
WO2008126076A2 (en) 2007-04-11 2008-10-23 Perrigo Israel Pharmaceuticals Ltd. Low-dose mometasone formulations
HUE027718T2 (en) 2009-05-12 2016-10-28 Galenica Ab Oil-in-water emulsion containing mometasone and propylene glycol
DK2429490T3 (en) 2009-05-12 2017-02-20 Galenica Ab OIL-IN-WATER EMULSION OF MOMETASON

Also Published As

Publication number Publication date
JP2012526738A (ja) 2012-11-01
CA2761739A1 (en) 2010-11-18
WO2010130428A1 (en) 2010-11-18
PL2429510T3 (pl) 2015-12-31
JP2015227354A (ja) 2015-12-17
PL2962688T3 (pl) 2020-11-02
CN102458382A (zh) 2012-05-16
RU2526911C2 (ru) 2014-08-27
RU2011150246A (ru) 2013-06-20
MX345888B (es) 2017-02-22
HUE027718T2 (en) 2016-10-28
EP2429510A1 (en) 2012-03-21
DK2429510T3 (en) 2015-09-28
US20140242171A1 (en) 2014-08-28
CA2761739C (en) 2017-03-07
NZ596429A (en) 2013-08-30
EP2962688B1 (en) 2020-06-24
US11395827B2 (en) 2022-07-26
AU2010246613B2 (en) 2014-07-17
ES2813400T3 (es) 2021-03-23
ES2547556T3 (es) 2015-10-07
BRPI1010907B1 (pt) 2020-10-20
BRPI1010907B8 (pt) 2021-05-25
BRPI1010907A2 (pt) 2016-03-15
MX2011011959A (es) 2012-05-08
CY1116667T1 (el) 2017-03-15
US8728497B2 (en) 2014-05-20
SI2429510T1 (sl) 2015-10-30
CN102458382B (zh) 2015-03-18
EP2962688A1 (en) 2016-01-06
PT2429510E (pt) 2015-10-12
EP2429510B1 (en) 2015-06-24
US20120171252A1 (en) 2012-07-05
HRP20150959T1 (hr) 2015-11-06
JP5833541B2 (ja) 2015-12-16
AU2010246613A1 (en) 2011-12-08

Similar Documents

Publication Publication Date Title
IL215516A0 (en) Emulsions of perfluorocarbons
BR112013013025A2 (pt) composições i-i e produtos e usos desta
DK2838549T3 (da) Farmaceutisk præparat til forebyggelse eller behandling af ikke-alkoholisk fedtleversygdom
BRPI1011587A2 (pt) compostos e composições terapèuticas
SMT201300044B (it) Circolazione di componenti durante omogeneizzazione di emulsioni
ITTO20110641A1 (it) Composizioni farmaceutiche e metodi di trattamento
SMT201700056B (it) Fosfaplatine e relativo utilizzo per il trattamento di cancro
FR2998419B1 (fr) Protection d'un circuit integre contre des attaques
BR112013006170A2 (pt) cosmético emulsificado do tipo água-em-óleo
SMT201500297B (it) Emulsione olio-in-acqua di mometasone e propilene glicole
SMT201600342B (it) Composizioni farmaceutiche topiche comprendenti mometasone furoato
FR2962044B1 (fr) Emulsion lacrymimetique
ES1072245Y (es) Dispositivo de encerrojamiento para corazon de punta movil
IT1403611B1 (it) Composizione di poliesteri
CO6852086A2 (es) Composiciones sólidas que contienen glicol éter y agua
FR2996373B1 (fr) Detection d'ilotage d'un onduleur
IT1400448B1 (it) Struttura di dispositivo di protezione
IT1402715B1 (it) Sonda di tastaggio
BR112012004701A2 (pt) compostos e composições para tratamento do câncer
IT1403062B1 (it) Metodo di piegatura di assorbenti igienici.
FR2965260B1 (fr) Composition neutralisante et biostatique pour fluides aqueux
SMT201600196B (it) Trattamento con porfirina di patologie neurodegenerative
HRP20170170T1 (hr) Emulzija ulje-u-vodi mometazona
CO6990712A2 (es) Combinación farmacéutica antineuritica y composiciones
IT1401335B1 (it) Doppio dispositivo ombelicale di identificazione madre-neonato